Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the PI3K/AKT Pathway

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - January 20, 2021 Category: Cancer & Oncology Authors: Dong Wang Zhijun Wang Xuedong Dai Liang Zhang Min Li Source Type: research